SMYD3 and breast carcinoma: Indeed, SMYD3 has been strongly implicated as a proto-oncogene in hepatocellular, colorectal and breast carcinomas [8–12] by virtue of its high over-expression and promoter-associated polymorphisms specific to malignant cells.